McKesson Net Income 2010-2024 | MCK

McKesson annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • McKesson net income for the quarter ending March 31, 2024 was $0.791B, a 0.51% increase year-over-year.
  • McKesson net income for the twelve months ending March 31, 2024 was $3.002B, a 15.67% decline year-over-year.
  • McKesson annual net income for 2024 was $3.002B, a 15.67% decline from 2023.
  • McKesson annual net income for 2023 was $3.56B, a 219.57% increase from 2022.
  • McKesson annual net income for 2022 was $1.114B, a 124.54% decline from 2021.
McKesson Annual Net Income
(Millions of US $)
2024 $3,002
2023 $3,560
2022 $1,114
2021 $-4,539
2020 $900
2019 $34
2018 $67
2017 $5,070
2016 $2,258
2015 $1,476
2014 $1,263
2013 $1,338
2012 $1,403
2011 $1,202
2010 $1,263
2009 $823
McKesson Quarterly Net Income
(Millions of US $)
2024-03-31 $791
2023-12-31 $589
2023-09-30 $664
2023-06-30 $958
2023-03-31 $787
2022-12-31 $1,079
2022-09-30 $926
2022-06-30 $768
2022-03-31 $368
2021-12-31 $-7
2021-09-30 $267
2021-06-30 $486
2021-03-31 $666
2020-12-31 $-6,226
2020-09-30 $577
2020-06-30 $444
2020-03-31 $1,021
2019-12-31 $186
2019-09-30 $-730
2019-06-30 $423
2019-03-31 $-796
2018-12-31 $469
2018-09-30 $499
2018-06-30 $-138
2018-03-31 $-1,146
2017-12-31 $903
2017-09-30 $1
2017-06-30 $309
2017-03-31 $3,588
2016-12-31 $633
2016-09-30 $307
2016-06-30 $542
2016-03-31 $431
2015-12-31 $634
2015-09-30 $617
2015-06-30 $576
2015-03-31 $132
2014-12-31 $472
2014-09-30 $469
2014-06-30 $403
2014-03-31 $370
2013-12-31 $65
2013-09-30 $404
2013-06-30 $424
2013-03-31 $259
2012-12-31 $298
2012-09-30 $401
2012-06-30 $380
2012-03-31 $521
2011-12-31 $300
2011-09-30 $296
2011-06-30 $286
2011-03-31 $422
2010-12-31 $155
2010-09-30 $327
2010-06-30 $298
2010-03-31 $348
2009-12-31 $326
2009-09-30 $301
2009-06-30 $288
2009-03-31 $281
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.372B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00